Azzariti, Amalia <br/><br/>
Tyrosine kinase inhibitors and multidrug resistance proteins: interactions and biological consequences.  [electronic resource] 

 -  Cancer chemotherapy and pharmacology  Jan 2010 
 - 335-46 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1432-0843 
<br/><br/><label>Standard No.: </label>10.1007/s00280-009-1039-0  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>ATP Binding Cassette Transporter, Subfamily B, Member 1--metabolism<br/>ATP Binding Cassette Transporter, Subfamily G, Member 2<br/>ATP-Binding Cassette Transporters--metabolism<br/>Animals<br/>Antineoplastic Agents--metabolism<br/>Biological Transport<br/>Camptothecin--analogs & derivatives<br/>Cell Line<br/>Cell Line, Tumor<br/>Dogs<br/>Doxorubicin--pharmacology<br/>Drug Resistance, Multiple<br/>Drug Resistance, Neoplasm<br/>Gefitinib<br/>Humans<br/>Irinotecan<br/>Mitoxantrone--pharmacology<br/>Neoplasm Proteins--metabolism<br/>Piperidines--metabolism<br/>Protein Kinase Inhibitors--metabolism<br/>Protein-Tyrosine Kinases--antagonists & inhibitors<br/>Quinazolines--metabolism<br/>Time Factors